Breast Cancer Research and Treatment View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1981

PUBLISHER

Springer US

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/10549

Recent publications latest 20 shown

  • 2019-04-12 Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms.
  • 2019-04-12 The association between mammographic density and breast cancer risk in Western Australian Aboriginal women.
  • 2019-04-12 Randomised clinical endpoint studies for trastuzumab biosimilars: a systematic review.
  • 2019-04-11 Improving surgical efficiency of immediate implant-based breast reconstruction following mastectomy.
  • 2019-04-11 Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1).
  • 2019-04-11 Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer.
  • 2019-04-10 Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer.
  • 2019-04-10 Temporal trends and regional variation in the utilization of low-value breast cancer care: has the Choosing Wisely campaign made a difference?
  • 2019-04-06 Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval.
  • 2019-04-06 Plasma B-vitamins and one-carbon metabolites and the risk of breast cancer in younger women.
  • 2019-04-06 Effects of physical and mind-body exercise on sleep problems during and after breast cancer treatment: a systematic review and meta-analysis.
  • 2019-04-05 Breast cancer research and treatment reconstruction of unilateral breast structure using three-dimensional ultrasound imaging to assess breast neoplasm.
  • 2019-04-04 Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues.
  • 2019-04-04 GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event.
  • 2019-04-02 Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer
  • 2019-04-02 Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
  • 2019-04 Patient-centered simulations to assess the usefulness of the 70-gene signature for adjuvant chemotherapy administration in early-stage breast cancer
  • 2019-04 Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours
  • 2019-04 Identifying adherence barriers to oral endocrine therapy among breast cancer survivors
  • 2019-04 Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
  • Subjects

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33160", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Oncology", 
            "type": "DefinedTerm"
          }
        ], 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.208", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "2.066", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2017", 
            "ratingValue": "3.605", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "3.626", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "4.085", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "3.940", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "4.198", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "4.859", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "4.696", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "4.469", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "4.431", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2008", 
            "ratingValue": "5.684", 
            "type": "Rating"
          }
        ], 
        "description": "

    Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a \"market place\" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.

    Oncology is undoubtedly the most rapidly growing subspecialty in the field of medicine, and breast cancer is one of the most serious problems of oncology. It is the leading cause of death of women in many countries, and is truly a multidisciplinary problem without geographic restrictions. Yet this very multidisciplinary aspect accounts for breast cancer literature appearing in any of the dozens of existing medical journals. None of these journals provides a focus on the unique problems of breast cancer. There has been no convenient arena for the discussion and resolution of ongoing controversies in breast cancer treatment, or for the consideration of thoughtful speculation and comments on current work. Breast Cancer Research and Treatment aims to fill this need.

    Each issue contains several articles dealing with original laboratory investigations and articles dealing with clinical studies. There are sections devoted to review articles, pro and con discussions of controversial subjects, meeting reports, and editorials. The panel discussions encourage experts to consider important topics.There is a section for letters to the editor, which provides for a lively exchange of opinions on previously published articles or other topics of interest. There is also an opportunity to publish the proceedings of special workshops, symposia, etc., devoted to breast cancer. All manuscripts are peer reviewed by a distinguished group of advisory editors from many countries covering all of the various disciplines of breast cancer.

    ", "editor": [ { "familyName": "Lippman", "givenName": "Marc", "type": "Person" } ], "id": "sg:journal.1092777", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0167-6806", "1573-7217" ], "license": "Hybrid (Open Choice)", "name": "Breast Cancer Research and Treatment", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "92777" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "10549" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "sn 82002391" ] }, { "name": "wos_id", "type": "PropertyValue", "value": [ "0167-6806/BREAST CANCER RESEARCH AND TREATMENT" ] }, { "name": "scopus_id", "type": "PropertyValue", "value": [ "28766" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "8111104" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "342632" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "15824" ] } ], "publisher": { "name": "Springer US", "type": "Organization" }, "publisherImprint": "Springer", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1092777" ], "sdDataset": "journals", "sdDatePublished": "2021-01-19T05:00", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///pack/app/journals_20190313_sn_only.jsonl", "startYear": "1981", "type": "Periodical", "url": "http://link.springer.com/journal/10549" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1092777'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1092777'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1092777'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1092777'


     

    This table displays all metadata directly associated to this object as RDF triples.

    146 TRIPLES      21 PREDICATES      41 URIs      36 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1092777 schema:about sg:ontologies/product-market-codes/H33160
    2 schema:contentRating N2a9e0a05f9874f68b1fc61b519d1895e
    3 N330fe7390a734f81a926e40b71b708ca
    4 N37f76178024747bf92560370aa10260c
    5 N4d586326e44c4c5daab896cd95430e04
    6 N5ebff7397c2040fa8bd2badf24b9f4bb
    7 N64d4e4dd65da4fba9fc6205f829301f6
    8 N699a96248f4a41f5ba1ad47001e17d80
    9 N8d9c3a9cdacd41c6b14d4f002d558de2
    10 Naff514b6f4ee43f8b40c76bd9a849094
    11 Ncb9e9ba00ca1465cb95168d946e21c03
    12 Nf10efccda1ed49ffa402b7211c919608
    13 Nff3e99cd71c34fa2a45cc221f6942f2e
    14 schema:description <p><i>Breast Cancer Research and Treatment</i> provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.<br/><br/>Oncology is undoubtedly the most rapidly growing subspecialty in the field of medicine, and breast cancer is one of the most serious problems of oncology. It is the leading cause of death of women in many countries, and is truly a multidisciplinary problem without geographic restrictions. Yet this very multidisciplinary aspect accounts for breast cancer literature appearing in any of the dozens of existing medical journals. None of these journals provides a focus on the unique problems of breast cancer. There has been no convenient arena for the discussion and resolution of ongoing controversies in breast cancer treatment, or for the consideration of thoughtful speculation and comments on current work. <i>Breast Cancer Research and</i> <i>Treatment</i> aims to fill this need.<br/><br/>Each issue contains several articles dealing with original laboratory investigations and articles dealing with clinical studies. There are sections devoted to review articles, pro and con discussions of controversial subjects, meeting reports, and editorials. The panel discussions encourage experts to consider important topics.There is a section for letters to the editor, which provides for a lively exchange of opinions on previously published articles or other topics of interest. There is also an opportunity to publish the proceedings of special workshops, symposia, etc., devoted to breast cancer. All manuscripts are peer reviewed by a distinguished group of advisory editors from many countries covering all of the various disciplines of breast cancer. </p>
    15 schema:editor Na1a3639c4190406ba1547168cf73aaaa
    16 schema:inLanguage en
    17 schema:isAccessibleForFree false
    18 schema:issn 0167-6806
    19 1573-7217
    20 schema:license Hybrid (Open Choice)
    21 schema:name Breast Cancer Research and Treatment
    22 schema:productId N09391fc0e3a44e96a1569d14774a88fb
    23 N2001b6ede3cd4667995cf22dfe619198
    24 N37aa3128be944f6fafb66ecc7364a68f
    25 N7bbd562ce36c479e99418615670809e0
    26 Nb41f7b8967ef4cb997fe04efb34ceb5a
    27 Nb5535b82456846f8a81e2f39b9012cd8
    28 Nc06ca92a0e084067b0f46203440941ca
    29 Nd4314e61be5349e8ab7dc2e857f31adb
    30 schema:publisher N514c46b9395f42018d0bdbff09ad442b
    31 schema:publisherImprint Springer
    32 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1092777
    33 schema:sdDatePublished 2021-01-19T05:00
    34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    35 schema:sdPublisher Nca9e493c36d44b8280337e70b3823df6
    36 schema:startYear 1981
    37 schema:url http://link.springer.com/journal/10549
    38 sgo:license sg:explorer/license/
    39 sgo:sdDataset journals
    40 rdf:type schema:Periodical
    41 N09391fc0e3a44e96a1569d14774a88fb schema:name lccn_id
    42 schema:value sn 82002391
    43 rdf:type schema:PropertyValue
    44 N106846c945e74e19801e4406cfbefa3c rdf:first impact_factor_wos
    45 rdf:rest rdf:nil
    46 N1a479aba56f04ed3b19e855e4f6e79e4 schema:familyName Lippman
    47 schema:givenName Marc
    48 rdf:type schema:Person
    49 N1d4346c2d5d74f14b06d1815eeee567d rdf:first impact_factor_wos
    50 rdf:rest rdf:nil
    51 N2001b6ede3cd4667995cf22dfe619198 schema:name springer_id
    52 schema:value 10549
    53 rdf:type schema:PropertyValue
    54 N2a9e0a05f9874f68b1fc61b519d1895e schema:author N94bd92a950604609b3961e7e2ea35b0c
    55 schema:dateCreated 2012
    56 schema:ratingValue 4.469
    57 rdf:type schema:Rating
    58 N330fe7390a734f81a926e40b71b708ca schema:author N62188ad930284d0aada781195287f2c0
    59 schema:dateCreated 2016
    60 schema:ratingValue 3.626
    61 rdf:type schema:Rating
    62 N37aa3128be944f6fafb66ecc7364a68f schema:name nlm_unique_id
    63 schema:value 8111104
    64 rdf:type schema:PropertyValue
    65 N37f76178024747bf92560370aa10260c schema:author Nfaa4d07aaaa248b0ab845555f52e184d
    66 schema:dateCreated 2017
    67 schema:ratingValue 3.605
    68 rdf:type schema:Rating
    69 N4d586326e44c4c5daab896cd95430e04 schema:author Ne780bb3782e34c64a885473d9d04fb2a
    70 schema:dateCreated 2011
    71 schema:ratingValue 4.431
    72 rdf:type schema:Rating
    73 N514c46b9395f42018d0bdbff09ad442b schema:name Springer US
    74 rdf:type schema:Organization
    75 N5ebff7397c2040fa8bd2badf24b9f4bb schema:author N1d4346c2d5d74f14b06d1815eeee567d
    76 schema:dateCreated 2010
    77 schema:ratingValue 4.859
    78 rdf:type schema:Rating
    79 N62188ad930284d0aada781195287f2c0 rdf:first impact_factor_wos
    80 rdf:rest rdf:nil
    81 N64d4e4dd65da4fba9fc6205f829301f6 schema:author Na1b0a25404f548cd88eab72566559f86
    82 schema:dateCreated 2009
    83 schema:ratingValue 4.696
    84 rdf:type schema:Rating
    85 N67236b58e7c04aef8475231bd29508d7 rdf:first impact_factor_wos
    86 rdf:rest rdf:nil
    87 N699a96248f4a41f5ba1ad47001e17d80 schema:author N7af9a28a435c4d0ca4e6922ec73ba99d
    88 schema:ratingValue 1.208
    89 rdf:type schema:Rating
    90 N7af9a28a435c4d0ca4e6922ec73ba99d rdf:first snip
    91 rdf:rest rdf:nil
    92 N7bbd562ce36c479e99418615670809e0 schema:name wos_id
    93 schema:value 0167-6806/BREAST CANCER RESEARCH AND TREATMENT
    94 rdf:type schema:PropertyValue
    95 N8d9c3a9cdacd41c6b14d4f002d558de2 schema:author Neaf840839987462c93b228ebb567a246
    96 schema:dateCreated 2008
    97 schema:ratingValue 5.684
    98 rdf:type schema:Rating
    99 N94bd92a950604609b3961e7e2ea35b0c rdf:first impact_factor_wos
    100 rdf:rest rdf:nil
    101 Na1a3639c4190406ba1547168cf73aaaa rdf:first N1a479aba56f04ed3b19e855e4f6e79e4
    102 rdf:rest rdf:nil
    103 Na1b0a25404f548cd88eab72566559f86 rdf:first impact_factor_wos
    104 rdf:rest rdf:nil
    105 Naff514b6f4ee43f8b40c76bd9a849094 schema:author N67236b58e7c04aef8475231bd29508d7
    106 schema:dateCreated 2014
    107 schema:ratingValue 3.940
    108 rdf:type schema:Rating
    109 Nb41f7b8967ef4cb997fe04efb34ceb5a schema:name era_ids_id
    110 schema:value 15824
    111 rdf:type schema:PropertyValue
    112 Nb5535b82456846f8a81e2f39b9012cd8 schema:name nsd_ids_id
    113 schema:value 342632
    114 rdf:type schema:PropertyValue
    115 Nc06ca92a0e084067b0f46203440941ca schema:name scopus_id
    116 schema:value 28766
    117 rdf:type schema:PropertyValue
    118 Nca9e493c36d44b8280337e70b3823df6 schema:name Springer Nature - SN SciGraph project
    119 rdf:type schema:Organization
    120 Ncb9e9ba00ca1465cb95168d946e21c03 schema:author Nf741fd724f0a472a8b5c5f7d3e6c1111
    121 schema:dateCreated 2013
    122 schema:ratingValue 4.198
    123 rdf:type schema:Rating
    124 Nd4314e61be5349e8ab7dc2e857f31adb schema:name dimensions_id
    125 schema:value 92777
    126 rdf:type schema:PropertyValue
    127 Nd5bd2d6ee52d451f8858b0fc349cc0bb rdf:first sjr
    128 rdf:rest rdf:nil
    129 Ne780bb3782e34c64a885473d9d04fb2a rdf:first impact_factor_wos
    130 rdf:rest rdf:nil
    131 Neaf840839987462c93b228ebb567a246 rdf:first impact_factor_wos
    132 rdf:rest rdf:nil
    133 Nf10efccda1ed49ffa402b7211c919608 schema:author N106846c945e74e19801e4406cfbefa3c
    134 schema:dateCreated 2015
    135 schema:ratingValue 4.085
    136 rdf:type schema:Rating
    137 Nf741fd724f0a472a8b5c5f7d3e6c1111 rdf:first impact_factor_wos
    138 rdf:rest rdf:nil
    139 Nfaa4d07aaaa248b0ab845555f52e184d rdf:first impact_factor_wos
    140 rdf:rest rdf:nil
    141 Nff3e99cd71c34fa2a45cc221f6942f2e schema:author Nd5bd2d6ee52d451f8858b0fc349cc0bb
    142 schema:ratingValue 2.066
    143 rdf:type schema:Rating
    144 sg:ontologies/product-market-codes/H33160 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    145 schema:name Oncology
    146 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...